Sponsor:
Tufts Medical Center
Code:
NCT06016517
Conditions
Arthritis, Rheumatoid
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Etanercept
Adalimumab
Upadacitinib
Tocilizumab
Brief summary:
Conditions
Arthritis, Rheumatoid
Study ID
NCT06016517
Start date
Dec 1, 2026
Status verified date
Nov, 2026
Completion date
Dec 15, 2028
Anticipated
Primary completion date
Dec 1, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
18 participants
Anticipated
Interventions
Etanercept
Adalimumab
Upadacitinib
Tocilizumab
Primary outcome measure
Central contacts
Locations
Tufts Medical Center
Recruiting
Boston, Massachusetts, United States, 02111
Sponsor
Tufts Medical Center
Last update posted
Nov 16, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by Tufts Medical Center on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.